Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Operations (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Cash from Operations for 15 consecutive years, with 1168609.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations fell 18.57% to 1168609.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 5868427.0, a 11.85% decrease, with the full-year FY2024 number at 5301292.0, up 33.96% from a year prior.
  • Cash from Operations was 1168609.0 for Q3 2025 at Creative Medical Technology Holdings, down from 1158747.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 222139.0 in Q2 2021 to a low of 3841642.0 in Q1 2023.
  • A 5-year average of 1434779.79 and a median of 1168609.0 in 2025 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: crashed 2137.93% in 2021, then soared 76.65% in 2024.
  • Creative Medical Technology Holdings' Cash from Operations stood at 1161336.0 in 2021, then plummeted by 209.23% to 3591234.0 in 2022, then surged by 47.23% to 1894983.0 in 2023, then fell by 2.88% to 1949536.0 in 2024, then soared by 40.06% to 1168609.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Cash from Operations are 1168609.0 (Q3 2025), 1158747.0 (Q2 2025), and 1591535.0 (Q1 2025).